» Articles » PMID: 23001869

The JNK/c-Jun Signaling Axis Contributes to the TDP-43-induced Cell Death

Overview
Publisher Springer
Specialty Biochemistry
Date 2012 Sep 25
PMID 23001869
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulation of transactive response DNA-binding protein-43 (TDP-43) is closely linked to the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). The contribution of the upregulation of TDP-43 expression to the pathogenesis has been strongly suggested by the observation that the level of TDP-43 expression is increased in both ALS and FTLD-U patients. We previously found that the low-grade (twice to five times more than the endogenous level) overexpression of TDP-43 induces neuronal cell death through the upregulation of Bim and CHOP expression and the downregulation of Bcl-xL expression. In this study, we further show that the low-grade overexpression of TDP-43 increases the level of phosphorylated c-Jun N-terminal kinase (JNK) and the co-incubation with a JNK inhibitor, the expression of a dominant-negative JNK, or the expression of a dominant-negative c-Jun inhibited the TDP-43-induced death in NSC34 motor neuronal cells. These data together suggest that the JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death.

Citing Articles

Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury.

Dogan E, Bouley J, Zhong J, Harkins A, Keeler A, Bosco D Acta Neuropathol Commun. 2023; 11(1):206.

PMID: 38124145 PMC: 10731794. DOI: 10.1186/s40478-023-01709-4.


Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.

Yang X, Ma Z, Lian P, Xu Y, Cao X Front Mol Neurosci. 2023; 16:1172197.

PMID: 37168679 PMC: 10164940. DOI: 10.3389/fnmol.2023.1172197.


Knowledge Graphs for Indication Expansion: An Explainable Target-Disease Prediction Method.

Gurbuz O, Alanis-Lobato G, Picart-Armada S, Sun M, Haslinger C, Lawless N Front Genet. 2022; 13:814093.

PMID: 35360842 PMC: 8963915. DOI: 10.3389/fgene.2022.814093.


Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease.

Benn C, Dawson L Front Aging Neurosci. 2020; 12:242.

PMID: 33117143 PMC: 7494159. DOI: 10.3389/fnagi.2020.00242.


The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.

Guo W, Vandoorne T, Steyaert J, Staats K, Van Den Bosch L Brain. 2020; 143(6):1651-1673.

PMID: 32206784 PMC: 7296858. DOI: 10.1093/brain/awaa022.


References
1.
Harris C, Johnson Jr E . BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem. 2001; 276(41):37754-60. DOI: 10.1074/jbc.M104073200. View

2.
Migheli A, Piva R, Atzori C, Troost D, Schiffer D . c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1997; 56(12):1314-22. DOI: 10.1097/00005072-199712000-00006. View

3.
Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351(3):602-11. DOI: 10.1016/j.bbrc.2006.10.093. View

4.
Tan C, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A . TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007; 113(5):535-42. DOI: 10.1007/s00401-007-0206-9. View

5.
Rothstein J . Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009; 65 Suppl 1:S3-9. DOI: 10.1002/ana.21543. View